華潤醫藥(03320.HK)擬進行系內貴州天安相關業務重組

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

華潤醫藥(03320.HK)擬進行系內貴州天安相關業務重組

阿思達克 09-28 09:20

華潤醫藥(03320.HK)公布，集團旗下華潤博雅生物及旗下博雅醫藥以對價約2.6億元將合計持有的天安藥業89.68%股權轉讓給集團旗下華潤雙鶴。目前，該事項已完成國有資產監督管理機構的評估備案。集團指，此次內部業務重組將進一步加強業務聚焦和劃分，推動華潤博雅生物聚焦主業發展及血液製品業務。

Relevant Stocks

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

華潤醫藥(03320.HK)擬進行系內貴州天安相關業務重組

Services

About Us

Agreement Statement